NCT04414540 2025-12-19Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer PatientsUniversity of CincinnatiPhase 2 Active not recruiting20 enrolled
NCT04114136 2025-02-10Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesUniversity of PittsburghPhase 2 Recruiting72 enrolled